相关实验视频
Updated: Aug 19, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
在急性心肌梗塞中进行血栓缓解治疗
1Center for Thrombosis and Vascular Research, University of Leuven, Belgium.
Circulation
|September 1, 1990
概括
血栓缓解剂,如链球激酶,阿尼斯特雷普拉斯和阿尔特雷普拉斯,可以改善再输并降低急性心肌梗塞的死亡率. 然而,出血风险,残留狭窄和重新封闭仍然是挑战,需要进一步研究抗血栓策略.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 血栓溶解疗法 血栓溶解疗法
背景情况:
- 血栓溶解剂激活了塑原到塑,这对于溶解血栓至关重要.
- 治疗急性心肌梗塞 (AMI) 时使用各种药物,包括链球激酶,安里斯特酶,沙鲁酶和阿尔特酶.
- 高剂量,短时间的疗法是常见的链球酶的管理.
研究的目的:
- 为了比较不同类型的血栓溶解剂在AMI中的疗效和安全性.
- 评估与血栓消毒疗法相关的再注射率,通透率和死亡率益处.
- 为了确定持续的挑战和未来的研究方向在AMI的血栓溶解治疗.
主要方法:
- 临床试验的综述,比较不同的血栓消毒剂 (链球激酶,安里斯特酶,沙鲁酶,阿尔特酶) 和安慰剂.
- 通过血管造影确定的反和通透率的分析.
- 来自随机试验的住院和30天死亡率数据的评估.
主要成果:
- 与链球激酶 (分别为43%和56%) 相比,阿尔特普拉斯的反射率 (69%) 和通透率 (75%) 较高.
- 血栓缓解药物治疗显著降低了死亡率:链杆激酶 (从12.0%降至9.47%),无位酶 (增加47%) 和高位酶 (在不同试验中分别减少27%和51%).
- 内出血是一个严重的风险,中风的发病率约为1.0-1.1%的阿尔特普拉斯和安慰剂组.
结论:
- 血栓溶解剂在AMI患者中提供显著的生存益处.
- 阿尔特普拉斯通常显示出优异的反和通透率.
- 需要进一步的研究来解决残留狭窄症,重新封闭,并优化抗血栓策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

